Biocon LimitedNSE: BIOCON

Press Release Apr 17 2024

· Issued by Biocon Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-apr-17-2024-5

Biocon Limited has informed the Exchange regarding a press release dated April 17, 2024, titled "Biocon Limited signs an exclusive licensing and supply agreement for generic Ozempic (Semaglutide) commercialization in Brazil with Biomm S.A.".

View Attachment

6ix hasn’t read this filing yet.

Biocon Limited on 6ix

Earlier from Biocon

Later from Biocon

All Biocon news releases